Respiratory News and Research

RSS

Winter grips Scotland with unprecedented rise in health concerns

Over three days of festivities Scotland’s NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24’s busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.

29 Dec 2010

Discovery Labs to implement reverse stock split

Discovery Laboratories, Inc. today announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the "Amendment") to effect a 1-for-15 share consolidation, or reverse stock split ("reverse split"), effective at 12:01 a.m. on December 28, 2010 (the "Effective Time").

28 Dec 2010

Placebos work

According to a new study people who knowingly take a dummy pill or placebo may benefit from it. These pills are usually made from sugar or other inert non-harmful materials. Usually when used in clinical trials patients are unaware whether they are taking the tested drug or a placebo to ensure the medical benefits of a potential new drug are assessed rigorously. However this new study published in the science journal PLoS ONE, found placebos may work even when patients are aware that they are taking them.

27 Dec 2010

Vitamin D levels of newborns appear to predict their risk of respiratory infections

The vitamin D levels of newborn babies appear to predict their risk of respiratory infections during infancy and the occurrence of wheezing during early childhood, but not the risk of developing asthma. Results of a study in the January 2011 issue of Pediatrics support the theory that widespread vitamin D deficiency contributes to risk of infections.

27 Dec 2010

Immunization with VLP vaccine results in functional, protective immune responses against RSV

Novavax, and scientists at the University of Massachusetts Medical School, led by Dr. Trudy Morrison, published in the January 2011 issue of The Journal of Virology, a report indicating that a novel virus-like particle vaccine candidate against respiratory syncytial virus (RSV) protects mice from a live virus challenge.

23 Dec 2010

National Nurses United calls for Senate approval of the James Zadroga 9/11 Health and Compensation Act

The nation's largest union, National Nurses United, and professional association of registered nurses urged the Senate to act now to pass the long-delayed bill to guarantee healthcare coverage for first responders, volunteers, and others adversely affected by the attack on the World Trade Center in 2001.

22 Dec 2010

Researchers develop new lung imaging technique that causes minimum tissue disruption

Fast-moving objects create blurry images in photography, and the same challenge exists when scientists observe cellular interactions within tissues constantly in motion, such as the breathing lung. In a recent UCSF-led study in mice, researchers developed a method to stabilize living lung tissue for imaging without disrupting the normal function of the organ.

21 Dec 2010

'CART' treatment better than traditional cognitive therapy at altering hyperventilation and panic symptoms

A new treatment program teaches people who suffer from panic disorder how to reduce the terrorizing symptoms by normalizing their breathing.

21 Dec 2010

Treatment with acid-suppressive drugs associated with increased risk of pneumonia

Using acid suppressive medications, such as proton pump inhibitors and histamine2 receptor antagonists, may increase the risk of developing pneumonia, states an article in CMAJ (Canadian Medical Association Journal).

21 Dec 2010

Study reveals nasal congestion can be a sign of severe asthma

Nasal congestion can be a sign of severe asthma, which means that healthcare professionals should be extra vigilant when it comes to nasal complaints. Furthermore, more severe asthma appears to be more common than previously thought, reveals a study from the Sahlgrenska Academy's Krefting Research Centre.

21 Dec 2010

SEEK announces new joint venture entity with Pernix Therapeutics for antitussive drug development

SEEK, a leading UK privately-owned drug-discovery group, is pleased to announce the establishment of a new joint venture entity with Pernix Therapeutics Holdings, an integrated specialty pharmaceutical company focused primarily on the United States pediatric market.

20 Dec 2010

Inspire's denufosol tetrasodium TIGER-1 Phase 3 trial for CF published in AJRCCM

Inspire Pharmaceuticals, Inc. announced today that the results from its first Phase 3 clinical trial with denufosol tetrasodium for cystic fibrosis (CF), TIGER-1, have been published in the peer-reviewed publication, American Journal of Respiratory and Critical Care Medicine (AJRCCM). Denufosol is an investigational, inhaled, novel ion channel regulator currently in Phase 3 clinical development for the treatment of CF.

20 Dec 2010

SAGE publishes first comprehensive textbook on psychology

Psychology for medicine, published today by SAGE, is the first comprehensive textbook on psychology for medical students that is relevant to all of their undergraduate studies.

20 Dec 2010

CF patients with normal to mildly impaired lung function may benefit from new investigational drug

Cystic fibrosis patients with normal to mildly impaired lung function may benefit from a new investigational drug designed to help prevent formation of the sticky mucus that is a hallmark of the disease, according to researchers involved in a phase 3 clinical trial of the drug.

19 Dec 2010

First comprehensive textbook on psychology for medical students

Psychology for medicine, published today by SAGE, is the first comprehensive textbook on psychology for medical students that is relevant to all of their undergraduate studies. Following the General Medical Council's call for greater coverage of psychology throughout medical degree courses, this groundbreaking textbook does just that - presenting all the psychology an undergraduate medical student needs to know.

17 Dec 2010

FDA clears Novavax's Phase I clinical trial to evaluate new RSV vaccine candidate

Novavax, Inc. announced today that the company's Phase I clinical trial to evaluate a new vaccine candidate to prevent respiratory syncytial virus (RSV) infection has been cleared by the U.S. Food and Drug Administration (FDA) and is no longer on clinical hold. In November, the company reported that it had received a question from the FDA regarding chemistry, manufacturing and controls (CMC) that has now been resolved.

16 Dec 2010

Discovery Labs awarded NIH Fast Track SBIR grant for developing aerosolized KL4 surfactant for RDS

Discovery Laboratories, Inc. today announced that the Company has been awarded Phase I of a Fast Track Small Business Innovation Research Grant (SBIR) from the National Institutes of Health (NIH) to support the development of the Company's program for aerosolizing KL4 surfactant for neonatal respiratory distress syndrome (RDS).

16 Dec 2010

Novel adenovirus-based gene therapy for renal cell carcinoma

Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus. Renal cell carcinoma is the most common form of kidney cancer in adults and currently there is no effective treatment for the disease once it has spread outside of the kidney.

16 Dec 2010

Tampa Hospital associates receive Transplant Excellence Award for lung transplant program

New Lung Associates PA and the Lung Transplant Program at Tampa General Hospital have received HealthGrades 2011 Organ Transplant Excellence Award. The award places Tampa General Hospital among the top three lung transplant programs in the nation.

16 Dec 2010

New nanotechnology based technique to detect pneumonia within minutes

University of Georgia researchers have developed a technique that can diagnose a common type of pneumonia within minutes, potentially replacing existing tests that can take several days for results.

15 Dec 2010

Respiratory News and Research

Winter grips Scotland with unprecedented rise in health concerns

Discovery Labs to implement reverse stock split

Placebos work

Vitamin D levels of newborns appear to predict their risk of respiratory infections

Immunization with VLP vaccine results in functional, protective immune responses against RSV

National Nurses United calls for Senate approval of the James Zadroga 9/11 Health and Compensation Act

Researchers develop new lung imaging technique that causes minimum tissue disruption

'CART' treatment better than traditional cognitive therapy at altering hyperventilation and panic symptoms

Treatment with acid-suppressive drugs associated with increased risk of pneumonia

Study reveals nasal congestion can be a sign of severe asthma

SEEK announces new joint venture entity with Pernix Therapeutics for antitussive drug development

Inspire's denufosol tetrasodium TIGER-1 Phase 3 trial for CF published in AJRCCM

SAGE publishes first comprehensive textbook on psychology

CF patients with normal to mildly impaired lung function may benefit from new investigational drug

First comprehensive textbook on psychology for medical students

FDA clears Novavax's Phase I clinical trial to evaluate new RSV vaccine candidate

Discovery Labs awarded NIH Fast Track SBIR grant for developing aerosolized KL4 surfactant for RDS

Novel adenovirus-based gene therapy for renal cell carcinoma

Tampa Hospital associates receive Transplant Excellence Award for lung transplant program

New nanotechnology based technique to detect pneumonia within minutes

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News